The EnvMed Network is a nonprofit organisation engaged in establishing Environmental Medicine in Europe. Given the increasing amount of harmful chemicals in the environment and the growing scientific evidence of correlations with chronic diseases, we are committed to reduce environmental exposures, promoting research into health links and treatments, better aligning medical care with these findings, and facilitating patient access to analysis.
The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc) which include important new medicines for the treatment of diseases…
For a toxic-free world: Nepal and Tanzania are in the running for prestigious policy prize…
The European Commission has published a draft legislation to phase out dental amalgam in 2025. The revision of the EU Mercury Regulation has been expected since December 2022 and includes a ban on mercury-containing lamps, effectively stoping all remaining intentional uses of mercury in the EU…
From 25th to 29th of September, the World Chemical Conference, ICCM5, will take place in Bonn, Germany. German Civil society organizations will host a half-day Civil Society Conference in Bonn on 22 September…
Geneva, 21 – 23 June 2023. Parties to the Minamata Convention not having implemented any or only a few of the required measures to restrict the use of mercury-added products were invited by the Secretariat to participate in a workshop to develop strategies…
The first in-person stakeholder forum meeting of the Partnership for the Assessment of the Risks from Chemicals (PARC) was held in Athens on 28 June 2023. The main achievements were presented and the priorities and needs of the stakeholders were discussed…
Global Overview of Countries Phasing Out Dental Amalgam: According to the Minamata Conventions Full National Reports 2021, the MIAs, or other official documents, the global transition to a mercury-free dentistry is fully underway…
Since the new Medical Devices Regulation (MDR 2017/745) entered into force on May 26, 2021, the legal safety requirements for dental amalgam capsules have increased significantly, why manufacturers start leaving the European business…
In line with the European Mercury Regulation (EU 2017/852), member states were required to submit National Action Plans (by 1 July 2019) to reduce the use of dental amalgam and preferably phase it out by 2030. 26 of 27 national plans were published…
Die Belastung mit Chemikalien betrifft alle. Sie überschreitet unsere planetaren Grenzen und zwingt uns angesichts von Erkrankungen und der Kontamination ganzer Ökosysteme zum entschlossenen Handeln…
EU-Kommission will Amalgamfüllungen 2025 verbieten / Kürzlich in den Global Dental Amalgam Tracker aufgenommen: Bolivien verbietet Amalgam seit 2019 / PARC: Stekeholder Forum Treffen …
Philippinen: Generelles Amalgam-Verbot tritt in Kraft / Afrika will Amalgam bis 2030 verbieten / MDR: Übergangsfrist für Amalgam-Zertifikate verlängert …
The health impact of chemicals in the environment is constantly increasing. There is a significant associated rise in neurological, autoimmune and cancer diseases. Male fertility decreases dramatically. However, when patients visit the doctor, hardly any examinations are carried out for possible chemical exposures.
We bring researchers and practitioners in the fields of metal biology, medicine and medical geology together to showcase the recent developments and address global challenges we face today within the field of metal toxicity.
Our mission is to advocate and support the adoption and implementation of a legally binding instrument which contains mandatory obligations to eliminate where feasible, and otherwise minimize, the global supply and trade of mercury, the global demand for mercury, anthropogenic releases of mercury to the environment, and human and wildlife exposure to mercury.
The European Network for Environmental Medicine is a non-profit organisation located in Berlin. Your direct donations enable us to work on reducing environmental exposures, promoting research into health links and treatments, better aligning medical care with these findings, and facilitating patient access to analysis.
